Tyrosine kinase inhibitors for advanced or metastatic thyroid cancer: a meta-analysis of randomized controlled trials. [electronic resource]
Producer: 20190916Description: 795-803 p. digitalISSN:- 1473-4877
- Antineoplastic Agents -- adverse effects
- Disease-Free Survival
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Humans
- Protein Kinase Inhibitors -- adverse effects
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Randomized Controlled Trials as Topic
- Thyroid Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.